BackLyell Immunopharma Overview

Lyell Immunopharma Other Current Assets

Track Lyell Immunopharma's other current assets ($9.4M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$9.44M
↑ 74.02% YoYΔ $4.01M vs prior year quarter

Peer average / median

Loading

Lyell Immunopharma Other Current Assets History

Loading

Lyell Immunopharma vs. peers: Other Current Assets Comparison

Loading

Lyell Immunopharma Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Lyell Immunopharma (LYEL) FAQ

As of the most recent data (June 2026), LYEL shows a other current assets of $9.4M. That compares with $5.4M in the prior-year period — up 74.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LYEL's other current assets is now $9.4M (was $5.4M) — a 74.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Lyell Immunopharma is outperforming or lagging.

Tracking LYEL's other current assets over time shows whether Lyell Immunopharma is scaling, shrinking, or reshaping that part of the business. The current reading is $9.4M That compares with $5.4M in the prior-year period — up 74.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has Lyell Immunopharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $9.4M) with ownership activity and broader fundamentals.

Lyell Immunopharma's other current assets is $9.4M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.